BullFrog AI Holdings (BFRG) Common Equity (2021 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Common Equity came in at $7.0 million in Q2 2026, up 219.33% on a YoY basis from $2.2 million in Q2 2025, and up 227.07% quarter-over-quarter from $2.1 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Common Equity (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Common Equity for 6 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 219.33% year-over-year to $7.0 million; the trailing twelve-month figure through Jun 2026 stood at $7.0 million (up 219.33% YoY), and the FY2025 full-year result was $2.1 million, down 56.96% from the prior year.
- Common Equity climbed to $7.0 million in Q2 2026 per BFRG's latest filing, from $2.1 million in the prior quarter.
- Across five years, Common Equity topped out at $7.0 million in Q2 2026 and bottomed at -$3.1 million in Q4 2022.
- Historically, Common Equity has averaged $2.6 million across 5 years, with a median of $3.2 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Common Equity slumped 202.98% in 2022, then soared 397.51% in 2023.
- Over 5 years, Common Equity stood at -$3.1 million in 2022, then soared by 184.79% to $2.6 million in 2023, then soared by 91.48% to $5.0 million in 2024, then slumped by 56.96% to $2.1 million in 2025, then jumped by 227.07% to $7.0 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $7.0 million, $2.1 million, and $1.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 11.69 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 11.83 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 20.25 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 31.71 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 8.42 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 6.76 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 18.85 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 757.49 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | 6.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.99 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 3.25 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 4.62 Mn |
| Dec 31, 2022 | -3.06 Mn |
| Sep 30, 2022 | -2.41 Mn |
| Jun 30, 2022 | -1.89 Mn |
| Mar 31, 2022 | -1.55 Mn |
| Dec 31, 2021 | -1.01 Mn |